July 25, 1994
Michael Marco works as a consultant for the Treatment Action Group (TAG) and heads its Oncology Project. An art historian and a member of the AIDS activist affinity group The Marys, Michael sits on the ACTG Oncology Committee's KS and Lymphoma Working Group, the NCI's ECOG AIDS Committee, and the Memorial Sloan-Kettering Cancer Center-New York Hospital/Cornell Medical Center ACTU Community Advisory Board (CAB).
Marty Majchrowicz works for AIDS Project Los Angeles (APLA) and writes for Positive Living and Being Alive Newsletter. He co-chairs the UCLA Community Advisory Board (CAB). Born and raised in Chicago, Marty currently resides in Los Angeles, where he received his BS in Biological Sciences at the University of Southern California (USC), and his Masters in Public Health at the University of California, Los Angeles (UCLA). He wrote the sections in this report on Epidemiology, Etiology and Pathogenesis.
The Treatment Action Group (TAG) fights to find a cure for AIDS and to ensure that all people living with HIV receive the necessary treatment, care, and information they need to save their lives. TAG focuses on the AIDS research effort, both public and private, the drug development process, and our nation's health care delivery systems. We meet with researchers, pharmaceutical companies, and government officials, and resort when necessary to acts of civil disobedience, or to acts of Congress. We strive to develop the scientific and political expertise needed to transform policy. TAG is committed to working for and with all communities affected by HIV.
Acknowledgements: First, thanks to go out to the members of TAG, especially Lynda Dee, Gregg Gonsalves, Barbara Hughes, Derek Link and Peter Staley, who not only supported and encouraged this project from the beginning, but also worked on advising and editing the writing of this report; and to colleagues at APLA, including Ruben Gamundi, Glenn Gaylord, Peter George, Doug Johnstone and Judie Klapholz. We also thank our medical advisor, Steve Miles, for his many hours of assistance and insights on research and treatment issues. Alvin Friedman